Gracell Biotechnologies I...

NASDAQ: GRCL · Real-Time Price · USD
10.25
0.01 (0.05%)
At close: Feb 21, 2024, 10:00 PM

Gracell Biotechnologies Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Net Income
-498.03M -609.03M -457.44M -305M -179.16M
Depreciation & Amortization
n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a n/a
Other Non-Cash Items
498.03M 609.03M 457.44M 305M 179.16M
Deferred Income Tax
n/a n/a n/a n/a n/a
Change in Working Capital
n/a n/a n/a n/a n/a
Operating Cash Flow
n/a n/a n/a n/a n/a
Capital Expenditures
n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a
Financial Cash Flow
n/a n/a n/a n/a n/a
Net Cash Flow
211.24M -471.23M -309.75M -145.44M -196.05M
Free Cash Flow
n/a n/a n/a n/a n/a